Biodyne Co., Ltd. (KOSDAQ:314930)
12,050
-240 (-1.95%)
At close: Apr 28, 2026
Biodyne Market Cap
Biodyne has a market cap or net worth of 358.66 billion as of April 28, 2026. Its market cap has increased by 2.12% in one year.
Market Cap
358.66B
Enterprise Value
339.00B
Revenue
4.98B
Ranking
n/a
PE Ratio
n/a
Stock Price
12,050.00
Market Cap Chart
Since March 17, 2021, Biodyne's market cap has increased from 252.12B to 358.66B, an increase of 42.26%. That is a compound annual growth rate of 7.13%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 28, 2026 | 358.66B | -10.74% |
| Dec 30, 2025 | 401.82B | -16.15% |
| Dec 30, 2024 | 479.20B | 19.24% |
| Dec 28, 2023 | 401.88B | 185.76% |
| Dec 29, 2022 | 140.63B | -31.74% |
| Dec 30, 2021 | 206.02B | -18.28% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| RecensMedical | 310.32B |
| M.I.TECH Co.,Ltd | 221.69B |
| Synergy Innovation | 186.79B |
| BIOBIJOU | 133.14B |
| Celemics | 130.63B |
| Livsmed | 1,522.16B |
| Curiox Biosystems | 1,551.06B |
| Corentec | 75.05B |